Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.92 USD | +0.35% | +2.63% | +0.45% |
May. 16 | GSK to Sell Remaining Stake in Haleon Valued at Around $1.27 Billion -- Update | DJ |
May. 16 | Global markets live: Cisco, EasyJet, Roche, Netflix, Amazon... |
Financials (USD)
Sales 2024 * | 60.41B | Sales 2025 * | 62.71B | Capitalization | 163B |
---|---|---|---|---|---|
Net income 2024 * | 7.78B | Net income 2025 * | 11.29B | EV / Sales 2024 * | 3.67 x |
Net Debt 2024 * | 58.11B | Net Debt 2025 * | 49.97B | EV / Sales 2025 * | 3.4 x |
P/E ratio 2024 * |
20.1
x | P/E ratio 2025 * |
14.1
x | Employees | 88,000 |
Yield 2024 * |
5.78% | Yield 2025 * |
5.88% | Free-Float | 59.05% |
Latest transcript on Pfizer, Inc.
1 day | +1.76% | ||
1 week | +2.63% | ||
Current month | +12.88% | ||
1 month | +12.57% | ||
3 months | +4.71% | ||
6 months | -2.86% | ||
Current year | +0.45% |
Managers | Title | Age | Since |
---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 62 | 92-12-31 |
David Denton
DFI | Director of Finance/CFO | 59 | 22-05-01 |
Jeff Settleman
CTO | Chief Tech/Sci/R&D Officer | - | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 20-03-31 | |
Ronald Blaylock
BRD | Director/Board Member | 64 | 17-02-22 |
Shantanu Narayen
BRD | Director/Board Member | 60 | 13-09-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.74% | 254 M€ | +10.74% | - | |
9.37% | 17 M€ | +7.62% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 28.92 | +0.35% | 40,077,782 |
24-05-15 | 28.82 | +1.55% | 38,376,257 |
24-05-14 | 28.38 | -0.21% | 23,530,856 |
24-05-13 | 28.44 | +1.54% | 39,609,758 |
24-05-10 | 28.01 | -0.60% | 25,849,775 |
Delayed Quote Nyse, May 16, 2024 at 04:01 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.45% | 163B | |
+32.36% | 709B | |
+30.77% | 595B | |
-1.60% | 367B | |
+20.07% | 334B | |
+6.04% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.27% | 171B |
- Stock Market
- Equities
- PFE Stock